[EFFECT] CollPlant Biotechnologies Ltd SEC Filing

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

EFFECT

Rhea-AI Filing Summary

Analyzing...

01/20/2026 - 12:15 AM

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	January 16, 2026 4:30 P.M.

Form:

F-3

CIK:	0001631487
Company Name:	CollPlant Biotechnologies Ltd
File Number:	333-292640

Source: View Original Filing on SEC EDGAR

Collplant Biotechnologies Ltd

NASDAQ:CLGN

CLGN Rankings

#6056 Ranked by Market Cap

N/A Ranked by Dividends

CLGN Latest News

Nov 26, 2025

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Nov 18, 2025

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTS

Oct 27, 2025

CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada

Oct 20, 2025

CollPlant's rhCollagen-Based BioInk Demonstrates Strong Performance Compared to Matrigel® in Study Conducted by Technion - Israel Institute of Technology

Oct 16, 2025

First-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInk

CLGN Latest SEC Filings

Nov 26, 2025

[6-K] CollPlant Biotechnologies Ltd Current Report (Foreign Issuer)

Nov 26, 2025

[6-K] CollPlant Biotechnologies Ltd Current Report (Foreign Issuer)

Oct 27, 2025

[6-K] CollPlant Biotechnologies Ltd Current Report (Foreign Issuer)

Oct 16, 2025

[6-K] CollPlant Biotechnologies Ltd Current Report (Foreign Issuer)

Oct 9, 2025

[144] CollPlant Biotechnologies Ltd SEC Filing

CLGN Stock Data

Market Cap 19.16M

Float 8.97M

Insiders Ownership 10.16%

Institutions Ownership 12.23%

Short Percent 0.33%

Industry Biotechnology

Sector Healthcare

Website Link

Country Israel

City Rehovot